Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the apoB/E receptor

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 1, 1997, Pages 149-155

  Olsson, Urban ^a   Camejo, Germán ^a,b   Hurt Camejo, Eva ^a   Elfsber, Karin ^a   Wiklund, Olof ^a   Bondjers, Göran ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

apoB 100; apoB E receptor; cell surface proteoglycans; LDL cell binding; LDL degradation

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN E; CHONDROITIN SULFATE; DERMATAN SULFATE; LIPOPROTEIN RECEPTOR; PROTEOGLYCAN;

ARTICLE; CELL ADHESION; CELL SURFACE; HUMAN; HUMAN CELL; INTERNALIZATION; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SEQUENCE HOMOLOGY;

EID: 0031036417     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.1.149     Document Type: Article

References (11)

1. Brown MS, Deuel TF, Basu SK, Goldstein JL. Inhibition of binding of low density lipoprotein to its cell surface receptors in human fibroblasts by positively charged proteins. J Supramol Struct. 1978;8:223-234.
2. Dyer CA, Curtiss LK. A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor. J Biol Chem. 1991;266:22803-22806.
3. Camejo G, Rosengren B, Olsson U, Bondjers G. Agarose isoelectric focusing of plasma low and very low density lipoproteins using the Phast system. Anal Biochem. 1989;182:94-97.
4. Milne R, Théolis R, Maurice R, Pease R, Weech P, Rassar E, Fruchart J-C, Scott J, Marcel Y. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J Biol Chem. 1989;264:19754-19760.
5. Lawn A, Scott J. A cross-species comparison of the apolipoprotein B domain that binds to the LDL receptor. J Lipid Res. 1990;31:1109-1120.
6. Camejo G, Olofsson S-O, López F, Carlsson P, Bondjers G. Identification of apo B-100 segments mediating the interaction of low-density lipoproteins with arterial proteoglycans. Arteriosclerosis. 1988;8:368-317.
7. Cardin AD, Weintraub HJ. Molecular modeling of protein-glycosaminoglycan interaction. Arteriosclerosis. 1989;9:21-32.
8. Camejo G, Rosengren B, Olsson U, López F, Olofsson S-O, Westerlund C, Bondjers G. Molecular basis of the association of arterial proteoglycans with low density lipoproteins: its effect on the structure of the lipoprotein particle. Eur Heart J. 1990;11(suppl E): 164-173.
9. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes. Physiol Rev. 1991;71:481 -539.
10. Olsson U, Camejo G, Olofsson S-O, Bondjers G. Molecular parameters that control the association of low density lipoprotein apoB-100 with chondroitin sulphate. Biochim Biophys Acta. 1991;1097:37-44.
11. Olsson U, Camejo G, Bondjers G. Binding of a synthetic apolipoprotein B-100 peptide and peptide analogues to chondroitin 6-sulfate: effects of the lipid environment. Biochemistry. 1993;32:1858-1865.